Humana stock slides

Cigna says it is not pursuing deal with rival Humana, shares jump
Cigna Group is not pursuing a combination with rival Humana, the health insurer said on Monday, days after Donald Trump's re-election as U.S. president raised investor hopes that the reported merger may pass antitrust scrutiny.
Humana stock slides as Cigna confirms it won’t pursue a combination
Humana shares drop 7% premarket as Cigna confirms it won't pursue combination with the managed care insurer.
Cigna Group Confirms It Isn't Looking to Acquire Humana
Late last year, The Wall Street Journal reported that Cigna was in talks with Humana for a healthcare merger but abandoned its pursuit after shareholders balked at a deal that would have created a roughly $140-billion health-insurance industry giant.
Cigna Group Reaffirms Outlook; Not Pursuing Combination With Humana
The Cigna Group said it plans to reaffirm projected full year 2024 consolidated adjusted income from operations of at least $28.40
Cigna says it is not pursuing combination with Humana
Health insurer Cigna Group said on Monday it is not pursuing a combination with peer Humana. Shares of Cigna rose 3.2% in premarket trading, while Humana fell nearly 3%. Cigna said it would only consider acquisitions that are "strategically aligned,
Humana Stock Tumbles. Cigna Won’t Pursue the Health Insurer.
Cigna won’t be pursuing a deal with Humana, the health insurer said Monday. In light of recent and persistent speculation, Cigna confirmed that it is not pursuing a combination with Humana, in a press release early Monday.
Hosted on MSN49m
Health insurer Cigna says it is not pursuing combination with rival Humana
(Reuters) - Cigna Group is not pursuing a combination with Humana, the health insurer said on Monday, following recent ...
Cigna Won't Do Humana Deal
Cigna said it isn't seeking to buy Humana, bolstering its stock and weighing on the share price of the Medicare-focused company. Cigna spoke out because of ongoing speculation it would strike a deal ...
Cautious Optimism: Humana’s Hold Rating Amid Market Challenges and Strategic Adjustments
Humana (HUM – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst on November 7. Analyst Whit Mayo ...
Humana Q3 Earnings Review: The Medicare Advantage Madness May Finally Be Over
Humana's stock has fallen over 30% due to rising healthcare utilization and CMS pushing back on insurer profits, impacting MA ...
Wall Street Journal51m
Stocks to Watch Monday: Coinbase, Tesla, Cigna, Humana
↗️ Trump Media (DJT): As the "Trump trade" continues, shares of the parent of the president-elect's social-media company rose ahead of the opening bell. ↗️ Tesla (TSLA): Shares of Tesla, run by Trump ...
Investing7h
Cigna confirms it is not seeking Humana merger - reports
Investing.com - Cigna Corp (NYSE:CI) has confirmed it is not pursuing a combination with its smaller peer Humana (NYSE:HUM) ...
Humana Reports $480 Million Profit Amid Rising Costs And Medicare Enrollment
Humana reported a $480 million profit and higher-than-expected growth of its Medicare Advantage business that has been hit with higher costs.
Modern Healthcare12d
Humana gives upbeat earnings report after setbacks
Humana has faced a series of shocks this year, including surprise jumps in expenses and a deterioration in crucial Medicare ...
Humana upgraded to Neutral at BofA after Trump win
As previously reported, BofA upgraded Humana (HUM) to Neutral from Underperform with a price target of $308, up from $247, on the results of ...